跳至主要内容
临床试验/KCT0004214
KCT0004214已完成未知

Ocular surface changes after combination therapy of hyaluronate 0.15% and hyaluronate 0.3% in dry eye patients.

Keimyung University Dongsan Medical Center0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • Individuals aged 19 or over who presented with the following criteria after usage of 0.15% HA in the run-in period were enrolled: bilateral DED no less than level 2, tear break-up time (TBUT) less than 10 seconds, corneal fluorescein staining (CFS) score of at least 1 or more by the National Eye Institute (NEI/Industry) grading system, and 33 or more ocular surface disease index (ODSI) severity scale.

排除标准

  • At the baseline examination, patients with mild DED (level 1), TBUT >10 seconds, CFS score <1, and ODSI score <33 (at end of run-in period) were excluded. Patients with previous ocular pathologies requiring treatment, previous corneal or intraocular surgery within 6 months of the screening visit, a punctal occlusion procedure within 1 month of the screening visit, use of soft contact lenses during the study, measured intraocular pressure over 25 mmHg at the screening visit, and a significant hypersensitivity reaction to HA, as well as patients who were pregnant, breastfeeding, or planning to become pregnant were also excluded.

研究者

相似试验